186 related articles for article (PubMed ID: 27806214)
1. The Importance of Extensive Intraoperative Peritoneal Lavage as a Promising Method in Patients with Gastric Cancer Showing Positive Peritoneal Cytology Without Overt Peritoneal Metastasis and Other Therapeutic Approaches.
Ilhan E; Alemdar A; Ureyen O; Bas K
J Invest Surg; 2017 Oct; 30(5):318-324. PubMed ID: 27806214
[TBL] [Abstract][Full Text] [Related]
2. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.
Kuramoto M; Shimada S; Ikeshima S; Matsuo A; Yagi Y; Matsuda M; Yonemura Y; Baba H
Ann Surg; 2009 Aug; 250(2):242-6. PubMed ID: 19638909
[TBL] [Abstract][Full Text] [Related]
3. [Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery].
Okada K; Fujiwara Y; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2363-5. PubMed ID: 22202383
[TBL] [Abstract][Full Text] [Related]
4. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.
Masuda T; Kuramoto M; Shimada S; Ikeshima S; Yamamoto K; Nakamura K; Yoshimatsu S; Urata M; Baba H
Int J Clin Oncol; 2016 Apr; 21(2):289-294. PubMed ID: 26296529
[TBL] [Abstract][Full Text] [Related]
5. Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells.
Shimada S; Tanaka E; Marutsuka T; Honmyo U; Tokunaga H; Yagi Y; Aoki N; Ogawa M
Gastric Cancer; 2002; 5(3):168-72. PubMed ID: 12378344
[TBL] [Abstract][Full Text] [Related]
6. Extended intraoperative peritoneal lavage as prophylactic peritoneal recurrence for locally advanced gastric cancer: a prospective randomized trial.
Rodríguez-Santiago J; Luna A; Garsot E; Aldeano A; Balagué C; Rada A
Clin Transl Oncol; 2021 Sep; 23(9):1857-1865. PubMed ID: 33792839
[TBL] [Abstract][Full Text] [Related]
7. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial.
Yang HK; Ji J; Han SU; Terashima M; Li G; Kim HH; Law S; Shabbir A; Song KY; Hyung WJ; Kosai NR; Kono K; Misawa K; Yabusaki H; Kinoshita T; Lau PC; Kim YW; Rao JR; Ng E; Yamada T; Yoshida K; Park DJ; Tai BC; So JBY;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):120-127. PubMed ID: 33253659
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
Misawa K; Mochizuki Y; Sakai M; Teramoto H; Morimoto D; Nakayama H; Tanaka N; Matsui T; Ito Y; Ito S; Tanaka K; Uemura K; Morita S; Kodera Y;
Br J Surg; 2019 Nov; 106(12):1602-1610. PubMed ID: 31573086
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy with S-1 and surgical resection for a mucinous gastric cancer with peritoneal dissemination.
Hamada M; Tsuji A; Iwata J; Nishioka Y; Ozaki K; Shima Y; Horimi T
Gastric Cancer; 2005; 8(1):50-4. PubMed ID: 15747176
[TBL] [Abstract][Full Text] [Related]
10. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemotherapy for gastric cancer with peritoneal dissemination].
Fujiwara Y; Doki Y; Takiguchi S; Miyata H; Yamazaki M; Nishida T; Monden M
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1923-5. PubMed ID: 18219854
[TBL] [Abstract][Full Text] [Related]
12. Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.
Nakayama I; Chin K; Matsushima T; Takahari D; Ogura M; Shinozaki E; Suenaga M; Ozaka M; Wakatsuki T; Ichimura T; Hiroki O; Yamaguchi K
Int J Clin Oncol; 2017 Dec; 22(6):1060-1068. PubMed ID: 28748355
[TBL] [Abstract][Full Text] [Related]
13. A systematic review and meta-analysis of gastric cancer treatment in patients with positive peritoneal cytology.
Cabalag CS; Chan ST; Kaneko Y; Duong CP
Gastric Cancer; 2015 Jan; 18(1):11-22. PubMed ID: 24890254
[TBL] [Abstract][Full Text] [Related]
14. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
15. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
[TBL] [Abstract][Full Text] [Related]
16. [S-1 monotherapy achieved twenty-month survival for peritoneal lavage cytology-positive gastric cancer patient undergoing noncurative resection].
Shimoyama S; Kiyokawa T; Nishida M; Seto Y
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1411-4. PubMed ID: 22996780
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination].
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamazaki M; Nishida T; Doki Y
Gan To Kagaku Ryoho; 2008 Nov; 35(12):1996-8. PubMed ID: 19106502
[TBL] [Abstract][Full Text] [Related]
18. Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.
Coccolini F; Catena F; Glehen O; Yonemura Y; Sugarbaker PH; Piso P; Ceresoli M; Montori G; Ansaloni L
Eur J Surg Oncol; 2016 Sep; 42(9):1261-7. PubMed ID: 27134147
[TBL] [Abstract][Full Text] [Related]
19. [A case report of the combination therapy with S-1 plus CDDP intraperitoneal chemotherapy for CY positive cancer patient].
Ishii Y; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Matsumoto H; Yamaguchi T; Nakano D
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2084-6. PubMed ID: 22202291
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology.
Ako E; Ohira M; Yamashita Y; Kubo N; Muguruma K; Yashiro M; Sawada T; Nakata B; Kato Y; Hirakawa K
Hepatogastroenterology; 2008; 55(86-87):1939-42. PubMed ID: 19102427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
